Sinotherapeutics Inc. A Free Cash Flow Generation Index

Latest as of December 2025: 0.56x

Sinotherapeutics Inc. A free cash flow generation index. Sinotherapeutics Inc. A (688247) has a Free Cash Flow Generation Index of 0.56x as of December 2025. Free cash flow of CN¥53.77 Million represents 1% of operating cash flow (CN¥95.33 Million).

FCF Generation Index

0.56x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥53.77 Million
CNY

Operating Cash Flow

CN¥95.33 Million
CNY

Capital Expenditures

CN¥41.56 Million
CNY

Free Cash Flow Generation Index of Sinotherapeutics Inc. A (2020–2025)

Free cash flow generation index of Sinotherapeutics Inc. A from 2020 to 2025. Historical FCF Generation Index trend for Sinotherapeutics Inc. A across 6 annual periods. See Sinotherapeutics Inc. A leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Sinotherapeutics Inc. A Free Cash Flow Generation Index by Year (2020–2025)

Sinotherapeutics Inc. A free cash flow generation index by year from 2020 to 2025. Year-by-year Free Cash Flow Generation Index for Sinotherapeutics Inc. A. For the full cash flow conversion analysis, see cash efficiency ratio of Sinotherapeutics Inc. A.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2025 0.56x CN¥53.77 Million CN¥95.33 Million CN¥41.56 Million ▲ +108.1%
2024 0.27x CN¥35.30 Million CN¥130.23 Million CN¥94.93 Million ▲ +113.5%
2023 -2.01x CN¥-26.00 Million CN¥12.96 Million CN¥38.96 Million ▼ -42.3%
2022 -1.41x CN¥-103.15 Million CN¥73.18 Million CN¥176.34 Million ▼ -258.3%
2021 0.89x CN¥129.77 Million CN¥145.77 Million CN¥16.01 Million ▲ +8.9%
2020 0.82x CN¥171.70 Million CN¥210.04 Million CN¥38.34 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).